Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients

Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients

Background: The purpose of this study was to assess the prognostic value of the monocyte-to-high-density lipoprotein ratio (MHR) as a marker of inflammation in patients diagnosed with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Galen 2023-12, Vol.12
Hauptverfasser: Sedigh, Hamid, Separham, Ahmad, Aslan-abadi, Naser, Javan-ajdadi, Reza, Mehravani, Kazem
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Galen
container_volume 12
creator Sedigh, Hamid
Separham, Ahmad
Aslan-abadi, Naser
Javan-ajdadi, Reza
Mehravani, Kazem
description Background: The purpose of this study was to assess the prognostic value of the monocyte-to-high-density lipoprotein ratio (MHR) as a marker of inflammation in patients diagnosed with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). Materials and Methods: This retrospective cross-sectional study was conducted on patients with a diagnosis of STEMI who underwent PCI between March 2021 and March 2022 at Madani Training and Research Hospital in Tabriz, Iran. Data regarding clinical and demographic properties, and laboratory parameters were obtained from medical records. Patients were categorized into two groups according to the median of admission MHR. Results: The study population consisted of 652 patients, 378 males (58%), and 275 females (42%), with a median age of 68 years (interquartile range: 57-77). Results showed that groups with higher MHR (>15.59) had higher rates of in-hospital mortality and higher major adverse cardiovascular events (MACEs) in comparison with the group featuring lower MHR (
doi_str_mv 10.31661/gmj.v12i.3126
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_31661_gmj_v12i_3126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_31661_gmj_v12i_3126</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_31661_gmj_v12i_31263</originalsourceid><addsrcrecordid>eNqVjz0LwjAQhoMoKOrqfKMOrfnAVGetVLAg6h5KSTViE0mi4L83Ef-A07139z7Dg9CE4JQRzsn80t7SF6EqrJR30IAyShPKslU35MVymdCMZ300du6GMSaEMcYXAyTyV3V_Vl4ZDaYBf5XwsOaijfOqhviT8d4abeq3l-ANFJs92EjAtCyOM1A6IKqt7BsO6x2cznm5g0coSO3dCPWa6u7k-DeHKN3m53WR1NY4Z2UjfqwgWHxNRDAR0UREE_Y38AFfmVFM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Sedigh, Hamid ; Separham, Ahmad ; Aslan-abadi, Naser ; Javan-ajdadi, Reza ; Mehravani, Kazem</creator><creatorcontrib>Sedigh, Hamid ; Separham, Ahmad ; Aslan-abadi, Naser ; Javan-ajdadi, Reza ; Mehravani, Kazem</creatorcontrib><description>Background: The purpose of this study was to assess the prognostic value of the monocyte-to-high-density lipoprotein ratio (MHR) as a marker of inflammation in patients diagnosed with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). Materials and Methods: This retrospective cross-sectional study was conducted on patients with a diagnosis of STEMI who underwent PCI between March 2021 and March 2022 at Madani Training and Research Hospital in Tabriz, Iran. Data regarding clinical and demographic properties, and laboratory parameters were obtained from medical records. Patients were categorized into two groups according to the median of admission MHR. Results: The study population consisted of 652 patients, 378 males (58%), and 275 females (42%), with a median age of 68 years (interquartile range: 57-77). Results showed that groups with higher MHR (&gt;15.59) had higher rates of in-hospital mortality and higher major adverse cardiovascular events (MACEs) in comparison with the group featuring lower MHR (&lt;15.59). Receiver operating characteristic (ROC) curves demonstrated that MHR could predict in-hospital mortality with a 75.7% sensitivity and 53.5% specificity, as well as predict MACE with 60.2% sensitivity and 59.7% specificity. Multivariate analyses indicated that MHR is an independent predictor of both in-hospital mortality (OR 1.05, 95% CI 1.02-1.08, P=0.002) and MACE (OR 1.05, 95% CI 1.02-1.08, P&lt;0.001). Conclusion: This research indicated that the rise in MHR was independently associated with a higher risk of MACE and in-hospital mortality in STEMI patients undergoing primary PCI.</description><identifier>ISSN: 2588-2767</identifier><identifier>EISSN: 2322-2379</identifier><identifier>DOI: 10.31661/gmj.v12i.3126</identifier><language>eng</language><ispartof>Galen, 2023-12, Vol.12</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sedigh, Hamid</creatorcontrib><creatorcontrib>Separham, Ahmad</creatorcontrib><creatorcontrib>Aslan-abadi, Naser</creatorcontrib><creatorcontrib>Javan-ajdadi, Reza</creatorcontrib><creatorcontrib>Mehravani, Kazem</creatorcontrib><title>Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients</title><title>Galen</title><description>Background: The purpose of this study was to assess the prognostic value of the monocyte-to-high-density lipoprotein ratio (MHR) as a marker of inflammation in patients diagnosed with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). Materials and Methods: This retrospective cross-sectional study was conducted on patients with a diagnosis of STEMI who underwent PCI between March 2021 and March 2022 at Madani Training and Research Hospital in Tabriz, Iran. Data regarding clinical and demographic properties, and laboratory parameters were obtained from medical records. Patients were categorized into two groups according to the median of admission MHR. Results: The study population consisted of 652 patients, 378 males (58%), and 275 females (42%), with a median age of 68 years (interquartile range: 57-77). Results showed that groups with higher MHR (&gt;15.59) had higher rates of in-hospital mortality and higher major adverse cardiovascular events (MACEs) in comparison with the group featuring lower MHR (&lt;15.59). Receiver operating characteristic (ROC) curves demonstrated that MHR could predict in-hospital mortality with a 75.7% sensitivity and 53.5% specificity, as well as predict MACE with 60.2% sensitivity and 59.7% specificity. Multivariate analyses indicated that MHR is an independent predictor of both in-hospital mortality (OR 1.05, 95% CI 1.02-1.08, P=0.002) and MACE (OR 1.05, 95% CI 1.02-1.08, P&lt;0.001). Conclusion: This research indicated that the rise in MHR was independently associated with a higher risk of MACE and in-hospital mortality in STEMI patients undergoing primary PCI.</description><issn>2588-2767</issn><issn>2322-2379</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqVjz0LwjAQhoMoKOrqfKMOrfnAVGetVLAg6h5KSTViE0mi4L83Ef-A07139z7Dg9CE4JQRzsn80t7SF6EqrJR30IAyShPKslU35MVymdCMZ300du6GMSaEMcYXAyTyV3V_Vl4ZDaYBf5XwsOaijfOqhviT8d4abeq3l-ANFJs92EjAtCyOM1A6IKqt7BsO6x2cznm5g0coSO3dCPWa6u7k-DeHKN3m53WR1NY4Z2UjfqwgWHxNRDAR0UREE_Y38AFfmVFM</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Sedigh, Hamid</creator><creator>Separham, Ahmad</creator><creator>Aslan-abadi, Naser</creator><creator>Javan-ajdadi, Reza</creator><creator>Mehravani, Kazem</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20231201</creationdate><title>Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients</title><author>Sedigh, Hamid ; Separham, Ahmad ; Aslan-abadi, Naser ; Javan-ajdadi, Reza ; Mehravani, Kazem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_31661_gmj_v12i_31263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sedigh, Hamid</creatorcontrib><creatorcontrib>Separham, Ahmad</creatorcontrib><creatorcontrib>Aslan-abadi, Naser</creatorcontrib><creatorcontrib>Javan-ajdadi, Reza</creatorcontrib><creatorcontrib>Mehravani, Kazem</creatorcontrib><collection>CrossRef</collection><jtitle>Galen</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sedigh, Hamid</au><au>Separham, Ahmad</au><au>Aslan-abadi, Naser</au><au>Javan-ajdadi, Reza</au><au>Mehravani, Kazem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients</atitle><jtitle>Galen</jtitle><date>2023-12-01</date><risdate>2023</risdate><volume>12</volume><issn>2588-2767</issn><eissn>2322-2379</eissn><abstract>Background: The purpose of this study was to assess the prognostic value of the monocyte-to-high-density lipoprotein ratio (MHR) as a marker of inflammation in patients diagnosed with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI). Materials and Methods: This retrospective cross-sectional study was conducted on patients with a diagnosis of STEMI who underwent PCI between March 2021 and March 2022 at Madani Training and Research Hospital in Tabriz, Iran. Data regarding clinical and demographic properties, and laboratory parameters were obtained from medical records. Patients were categorized into two groups according to the median of admission MHR. Results: The study population consisted of 652 patients, 378 males (58%), and 275 females (42%), with a median age of 68 years (interquartile range: 57-77). Results showed that groups with higher MHR (&gt;15.59) had higher rates of in-hospital mortality and higher major adverse cardiovascular events (MACEs) in comparison with the group featuring lower MHR (&lt;15.59). Receiver operating characteristic (ROC) curves demonstrated that MHR could predict in-hospital mortality with a 75.7% sensitivity and 53.5% specificity, as well as predict MACE with 60.2% sensitivity and 59.7% specificity. Multivariate analyses indicated that MHR is an independent predictor of both in-hospital mortality (OR 1.05, 95% CI 1.02-1.08, P=0.002) and MACE (OR 1.05, 95% CI 1.02-1.08, P&lt;0.001). Conclusion: This research indicated that the rise in MHR was independently associated with a higher risk of MACE and in-hospital mortality in STEMI patients undergoing primary PCI.</abstract><doi>10.31661/gmj.v12i.3126</doi></addata></record>
fulltext fulltext
identifier ISSN: 2588-2767
ispartof Galen, 2023-12, Vol.12
issn 2588-2767
2322-2379
language eng
recordid cdi_crossref_primary_10_31661_gmj_v12i_3126
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title Evaluation of the prognostic value of monocyte to HDL ratio (MHR) in primary PCI STEMI patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A59%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20prognostic%20value%20of%20monocyte%20to%20HDL%20ratio%20(MHR)%20in%20primary%20PCI%20STEMI%20patients&rft.jtitle=Galen&rft.au=Sedigh,%20Hamid&rft.date=2023-12-01&rft.volume=12&rft.issn=2588-2767&rft.eissn=2322-2379&rft_id=info:doi/10.31661/gmj.v12i.3126&rft_dat=%3Ccrossref%3E10_31661_gmj_v12i_3126%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true